News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Fangmeinuo Wu

Articles by Fangmeinuo Wu

4 Bacopaside: Exploring Its Potential in Addressing Chemoresistance and Modulating Doxorubicin Accumulation in Triple-Negative Breast Cancer Cells

4 Bacopaside: Exploring Its Potential in Addressing Chemoresistance and Modulating Doxorubicin Accumulation in Triple-Negative Breast Cancer Cells

BySima K. Rad,Kenny K. L. Yeo,Runhao Li,Saifei Liu,Fangmeinuo Wu,Kevin A. Fenix,Timothy J. Price,Wendy Ingman,Amanda R. Townsend,Eric Smith

August 29th 2024

Latest Updated Articles

Trending on CancerNetwork

MARIPOSA Final OS Results in Asia Population Yield Meaningful Improvement in EGFR NSCLC

Linvoseltamab Yields High Response in Newly Diagnosed Multiple Myeloma

T-DM1 Confers Lower Cardiotoxicity Risk in HER2+ Advanced Breast Cancer

Novel Treatment Displays Tolerability in Relapsed/Refractory B-Cell ALL

Novel Microbiome-Based Therapy Safe, Tolerable in GI-aGVHD

© 2025 MJH Life Sciences^®

All rights reserved.